Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Amsterdam’s Phosphoenix raises €1.3 million to advance its neuroprosthetic system for people with profound blindness, with support from existing investors and ROM InWest.

PRIVATESep 18, 2026about 3 hours ago

Amount Raised

€1.3 Million

Round Type

Seed

AmsterdamBiotechnologyHealth Care

Investors

Rom In WestInnovatiefonds Noord HollandFirst FundTtt Medtech Fund

Description

Phosphoenix, a MedTech startup, has raised €1.3 million to advance its neuroprosthetic system for individuals with profound blindness. This funding will support the company's first-in-human clinical study and the development of its neurostimulation technology. The financing was supported by existing investors including TTT Medtech Fund and FIRST Fund, along with new investor ROM InWest. This marks a significant step towards clinical application and future Series A financing.

Company Information

Company

Phosphoenix

Location

Amsterdam, North Holland, Netherlands

About

Phosphoenix is an Amsterdam-based MedTech startup focused on developing a neuroprosthetic system intended to restore functional vision for individuals with profound blindness. Founded in 2019, the company aims to stimulate nerve cells in the visual perception areas of the brain, addressing an unmet need in effective blindness treatments. Their technology involves a proprietary high-density neural interface designed for implantation in the lateral geniculate nucleus of the brain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Phosphoenix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Predictive Intelligence
Strategic

ML-powered predictions for Phosphoenix's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Phosphoenix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.